New findings are coming out on almost a weekly basis about trace elements of gadolinium left in human tissue after scans with MRI contrast agents. What do we know about this phenomenon, and how serious is it? We talk to Dr. Robert McDonald, PhD, of the Mayo Clinic in Rochester, MN.
Video Interview 2018 RSNAVideo from RSNA 2018: What do we know about gadolinium deposition?
Nov 26, 2018
Latest in MRI
Cardiac MRI flags late gadolinium enhancement in Takotsubo patients
February 26, 2026
Azurity Pharmaceuticals launches Ferabright MRI contrast agent
February 26, 2026
GEHC, UCSF Health ink 10-year imaging collaboration
February 26, 2026




















